Patent Protection for AI in China: New Guidelines and References

The number of Chinese patent applications in the field of artificial intelligence is growing rapidly – the bottom line is that companies based in China have filed more than 440,000 AI patents by October 2019. Applicants are mostly large companies such as Baidu, Alibaba, Tencent, Inspur and Huawei as well as universities or research centers,… Continue reading Patent Protection for AI in China: New Guidelines and References

Defensive Trademark Application as Inexpensive Brand Protection Strategy

In order to counter the proliferation of bad faith trademark applications by counterfeiters, foreign companies should not only register their own trademarks in China, but also trademarks with similar words, signs and designs as defensive trademarks. Although these defensive trademarks can be cancelled after three consecutive years for non-use, their registration is cheaper than other… Continue reading Defensive Trademark Application as Inexpensive Brand Protection Strategy

Better Protection through Copyright Law

Copyright is becoming more and more important in China. The number of registrations has been increasing by 20 to 30% for years, the number of software copyrights has even increased by 36% in 2019. This reflects not only the growth in new technologies in areas such as cloud computing, AI or IoT, but also the… Continue reading Better Protection through Copyright Law

IP Databases Reduce Costs of Infringement Proceedings

COVID-19 also leads to companies paying closer attention to costs when enforcing their intellectual property rights in China. IP databases can help them do this. The analysis of Chinese court decisions in comparable cases enables IP managers and their service providers to correctly assess the case and the opponent and to find the right strategy.… Continue reading IP Databases Reduce Costs of Infringement Proceedings

Epidemic-related Trademark Applications are Rejected in China

It was to be expected: In China, in connection with the epidemic, countless individuals and companies are registering trademarks related to Corona. By 16 March 2020, the China National Intellectual Property Administration (CNIPA) had received more than 1,580 trademark applications in this regard, 328 of which were rejected. CNIPA rejects trademark applications such as “火神山”,… Continue reading Epidemic-related Trademark Applications are Rejected in China

China Loses the Battle for the WIPO Chairmanship

China has lost the battle for the chairmanship of the World Intellectual Property Organisation (WIPO), the UN organization regulating the international protection of intellectual property in Geneva. The new Director General will be Daren Tang, previously Chief Executive Officer of the Intellectual Property Office in Singapore (IPOS). The decision against the Chinese candidate Wang Binying,… Continue reading China Loses the Battle for the WIPO Chairmanship

Extension of the Patent Term: A Driver for Innovation

The trade agreement between the USA and China provides for the extension of the patent term of innovative medical devices to avoid undue delays. This is to the benefit of pharmaceutical companies in both countries. The contractual clause not only supports pharmaceutical manufacturers from the USA, it also benefits innovative Chinese pharmaceutical companies. These companies… Continue reading Extension of the Patent Term: A Driver for Innovation

Intellectual Property in China: More, Faster and Better

The China National Intellectual Property Administration (CNIPA) has presented the registration figures for 2019. Foreign applications of intellectual property in China increased again last year. In 2019, the number of patent applications of inventions filed by foreign applicants reached 157,000, an increase of 6% over the previous year. The number of foreign trademark applications rose… Continue reading Intellectual Property in China: More, Faster and Better

Economic and Trade Agreements also Protects the Pharmaceutical Industry

The trade agreement between the USA and China also includes the protection of intellectual property rights for the pharmaceutical industry. The focus is on drugs against cancer, diabetes, high blood pressure and stroke. The intention of the agreement is to promote the development of new treatments and cures for these diseases through better patent protection.… Continue reading Economic and Trade Agreements also Protects the Pharmaceutical Industry

Confidential Information are Trade Secrets

The economic and trade agreement signed by the USA and China on 15 January 2020 (phase one) contains prominent provisions on the protection of trade secrets. The content of the agreement includes not only procedural decisions such as burden sharing in civil proceedings, interim measures to prevent the use of trade secrets or criminal proceedings… Continue reading Confidential Information are Trade Secrets